Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Maternal Diabetes and the Hidden Risk of ROP
Pediatric Retina News

Maternal Diabetes and the Hidden Risk of ROP

Retrospective cohort study links maternal diabetes to increased ROP risk in premature infants

4/7/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: Maternal Diabetes and the Hidden Risk of ROP

Overview

A study of over 3,100 premature infants reveals that in-utero exposure to maternal diabetes significantly increases the risk of severe retinopathy of prematurity (ROP). Specifically, Type 1 and Type 2 diabetes were associated with more than sixfold increased odds of developing advanced ROP stages.

Background

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness globally, and identifying risk factors is crucial for improving screening and management strategies. Current screening protocols primarily focus on gestational age and birth weight, potentially overlooking maternal health factors such as diabetes. Understanding the implications of maternal diabetes on ROP progression could enhance early detection and intervention efforts.

Data Highlights

{'Odds of severe ROP with maternal diabetes': 'nearly 3 times'}

Key Findings

{'Gestational diabetes has a weaker, non-significant association with severe ROP.': 'Gestational diabetes shows a non-significant association with severe ROP.'}

Clinical Implications

{'Consider adding specific recommendations for screening adjustments based on maternal diabetes.': 'Consider adding specific recommendations for screening adjustments based on maternal diabetes.'}

Conclusion

The findings underscore the importance of recognizing maternal diabetes as a significant contributor to ROP progression. Integrating maternal health factors into current screening practices may enhance risk assessment and improve outcomes for premature infants.

References

  1. Ophthalmology Management, 2017 -- In pregnancy, the retina ‘works’ for two
  2. Retinal Physician, 2022 -- The Impact of Pregnancy on Diabetic Retinopathy and Its Implications
  3. Retinal Physician, 2025 -- Incorporating AI Into Global ROP Care
  4. PubMed -- Screening Examination of Premature Infants for Retinopathy of Prematurity
  5. ScienceDirect -- Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity
  6. Retinal Physician — Adult ROP: Late Complications of Retinopathy of Prematurity
  7. Screening Examination of Premature Infants for Retinopathy of Prematurity - PubMed
  8. Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity - ScienceDirect
  9. Freeze Treatment Reduces Blindness in Premature Infants | National Eye Institute

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: